Oramed Pharmaceuticals (NASDAQ:ORMP) is a clinical-stage biopharmaceutical company specializing in the development of proprietary oral drug delivery systems. Founded in 2006 and headquartered in Jerusalem with U.S. offices in New York, Oramed’s core focus is on transforming injectable therapies into orally administered formulations. The company was established by Dr. Nadav Kidron, who remains at the helm as Chief Executive Officer, guiding Oramed’s strategy to address chronic diseases through patient-friendly oral alternatives.
Oramed’s lead candidate, ORMD-0801, is an oral insulin capsule designed to improve glycemic control in patients with type 2 diabetes. This product has advanced through multiple Phase II clinical trials, demonstrating the potential to reduce postprandial glucose excursions and lower HbA1c levels. In addition to insulin, Oramed is advancing ORMD-0901, an oral formulation of exenatide, and a proprietary oral GLP-1 analog program aimed at obesity and metabolic syndrome, highlighting the company’s commitment to innovation in metabolic disease management.
The company operates globally, conducting clinical trials and forging strategic partnerships across North America, Europe, India and Asia. In 2021, Oramed launched Oravax Medical, a subsidiary focused on developing an oral COVID-19 vaccine; it has since expanded its pipeline to include oral vaccine candidates for influenza and other respiratory pathogens. Oramed’s collaborations with academic institutions and contract manufacturers in India and China further underscore its strategy to accelerate development and broaden market access.
Under the leadership of CEO Nadav Kidron and a management team with extensive experience in pharmaceutical R&D, regulatory affairs and commercialization, Oramed is positioned to address significant unmet needs in diabetes care and beyond. The company continues to leverage its proprietary Capsule Technology Platform to advance multiple oral therapeutic candidates, aiming to improve patient adherence and outcomes in chronic disease treatment.
